4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:分子类,蛋白类,抗体类,生化类试剂
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > bioporto/抗表面活性蛋白D(人,hSP-D)/1kit/HYB 246-04
商品详细bioporto/抗表面活性蛋白D(人,hSP-D)/1kit/HYB 246-04
bioporto/抗表面活性蛋白D(人,hSP-D)/1kit/HYB 246-04
bioporto/抗表面活性蛋白D(人,hSP-D)/1kit/HYB 246-04
商品编号: HYB246-04
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Cat. No.
HYB 246-04
Specificity
HYB 246-04 is specific for SP-D from amniotic fluid, serum and bronchioalveolar lavage. HYB 246-04 does not influence SP-D’s binding to carbohydrates, but block binding to GP-340.
Immunogen
Native human SP-D purified from late pregnancy amniotic fluid
Host
Mouse
Positive Species Reactivity
Human
Negative Species Reactivity
Not determined
Isotype
IgG2a/k
Gene ID
6441
Clone Number
10B2
Epitope Specificity
Epitope is localised within the C-terminal neck CRD (carbohydrate recognition domain) of SP-D
Unit Size
200 µL: Cat. No. HYB 246-04-021 mL: Cat. No. HYB 246-04-11 mg/mL +/- 15%. See Certificate of Analysis for details.
Purification
Protein A/G purified (from culture supernatant)
Form
Liquid
Solvent
0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide
Conjugation
Unconjugated BSA free
Storage
4-8ºC without exposure to light. No precautions necessary during handling.
Target
Surfactant protein D (SP-D) is synthesized and secreted by lung epithelial cells. It belongs to group III of the family of C-type lectins and members of this group has overall structure consisting of multiple globular "head" regions linked by triple-helical, collagen-like, strands. This group also includes SP-A and the serum proteins mannan-binding protein, conglutinin and collectin-43, all of which have been shown to bind to the C1q receptor found on a wide variety of cells. Both SP-D and SP-A have been shown to enhance oxygen radical production by alveolar macrophages. The serum concentration is approximately 700 ng/ml in healthy individuals. (1)
品牌介绍
  丹麦Bioporto公司成立于2000年,致力于开发抗体产品及诊断试剂盒。2005年首次开发出NGAL ELISA 试剂盒,该产品于2006年获得欧盟CE认证,可用于急性肾功能损伤的临床诊断和监测。其目标是开发出更多的临床诊断专利产品。